Skip to Content

Generic Soltamox Availability

Soltamox is a brand name of tamoxifen, approved by the FDA in the following formulation(s):

SOLTAMOX (tamoxifen citrate - solution;oral)

  • Manufacturer: MIDATECH PHARMA US
    Approval date: October 29, 2005
    Strength(s): EQ 20MG BASE/10ML

Has a generic version of Soltamox been approved?

No. There is currently no therapeutically equivalent version of Soltamox available in the United States.

Note: Fraudulent online pharmacies may attempt to sell an illegal generic version of Soltamox. These medications may be counterfeit and potentially unsafe. If you purchase medications online, be sure you are buying from a reputable and valid online pharmacy. Ask your health care provider for advice if you are unsure about the online purchase of any medication.

See also: Generic Drug FAQs.

Related Patents

Patents are granted by the U.S. Patent and Trademark Office at any time during a drug's development and may include a wide range of claims.

  • Oral liquid medicine solution
    Patent 6,127,425
    Issued: October 3, 2000
    Inventor(s): Tully; Roger Edward
    Assignee(s): Akzo Nobel N.V.

    Found is a pharmaceutical preparation which provides Tamoxifen Citrate in a liquid dosage form, viz. as an oral solution. The finding is based on a solvent comprising the following components: (a) of from 10% to 20% by weight of ethanol, (b) of from 10% to 60% by weight of a glycol; and (c) water, optionally containing additives, in a volume percentage adding up to 100% by volume. A preferred additive is sorbitol.

    Patent expiration dates:

    • June 26, 2018
      Drug product

Further information

Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.

Drug PatentA drug patent is assigned by the U.S. Patent and Trademark Office and assigns exclusive legal right to the patent holder to protect the proprietary chemical formulation. The patent assigns exclusive legal right to the inventor or patent holder, and may include entities such as the drug brand name, trademark, product dosage form, ingredient formulation, or manufacturing process A patent usually expires 20 years from the date of filing, but can be variable based on many factors, including development of new formulations of the original chemical, and patent infringement litigation.
Drug ExclusivityExclusivity is the sole marketing rights granted by the FDA to a manufacturer upon the approval of a drug and may run simultaneously with a patent. Exclusivity periods can run from 180 days to seven years depending upon the circumstance of the exclusivity grant.